Paul Shore

Paul Shore is a seasoned expert in clinical research and pediatric critical care, currently serving as the Global Clinical Program Director for Transplant at CSL Behring since November 2017. In this role, Paul oversees the clinical development of immunomodulatory biologics for organ transplantation. Additionally, Paul has been an Attending Physician at St. Christopher's Hospital for Children since 2013, providing emergency clinical care and medical education. Previous positions include Senior Director of Clinical Research at Windtree Therapeutics, Director of Clinical Research at Teva Pharmaceuticals, and various academic roles at Drexel University College of Medicine and University of Texas Southwestern Medical Center. Paul holds an MD from Hahnemann University School of Medicine and a Master's degree in Clinical Research from the University of Pittsburgh.